A biotech investor, Dr. Lindsay Rosenwald has contributed to the development of several key tools in the fight against cancer. As the initial backer and co-founder of Cougar Biotechnology, Inc., Dr. Lindsay Rosenwald helped to rescue the cancer drug that eventually became Zytiga from obscurity and ushered it through its early clinical trials.

1. INFORMATION ON
ZYTIGA
By Lindsay Rosenwald

2. Introduction

A biotech investor, Dr. Lindsay Rosenwald has
contributed to the development of several key
tools in the fight against cancer. As the initial
backer and co-founder of Cougar
Biotechnology, Inc., Dr. Lindsay Rosenwald
helped to rescue the cancer drug that
eventually became Zytiga from obscurity and
ushered it through its early clinical trials.

3. About Zytiga

Zytiga is used to treat prostate cancer that has
proven resistant to testosterone-lowering
treatments, including surgical intervention.
When prescribed in conjunction with the drug
prednisone, Zytiga has been shown to
increase survival times and slow the
progression of cancer. Zytiga has also allowed
patients to wait significantly longer before
starting chemotherapy.

4. Conclusion

The drug works by inhibiting the production of
hormones known as androgens, which play a
significant role in the development of prostate
cancer. By reducing the production of
androgens in two organs and at the site of the
tumor itself, the drug helps to fight the growth
of the cancer. Like other treatments, Zytiga
can cause serious side effects. For complete
information on the drug, visit Zytiga.com.